Deltex Medical Regulatory News (DEMG)

22 May 2015

Deltex Medical Group plc

("the Company" or "Deltex Medical")

Director's holding

Julian Cazalet, non-executive director, has notified the Company that due to an administrative oversight in reporting, his beneficial holding of 1p ordinary shares in the Company is 189,314 greater than previously reported.

The additional shares were acquired on Mr Cazalet's behalf at a price of 11p per share in June 2014 as a consequence of managed funds of which Mr Cazalet is the beneficiary subscribing for shares in the Company's Open Offer. The subscription cost of these shares of £20,825 was in addition to the £50,000 that Mr Cazalet invested directly in acquiring 454,545 ordinary shares as part of the Placing in June 2014, as announced at the time.

After inclusion of the additional shares, Mr Cazalet is the beneficial owner of 4,872,123 ordinary shares of 1p each representing 2.27% of the Company's issued share capital.

For further information: